Multisite Advancement of Research on Chronic Posttraumatic Headache
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Study ID
- NCT05620719
- Status
- Recruiting
Conditions
- Posttraumatic Headache
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cognitive Behavioral Therapy for Posttraumatic Headache — BEHAVIORALCBT for Posttraumatic Headaches consists of 8 sessions of cognitive behavioral therapy that focus on (1) discussions and exercises that increase awareness of what may be related to headaches, (2) relaxation techniques to manage physiological stress, and (3) problem-solving techniques to manage common stressors. Sessions are delivered weekly and can last between 45 to 75 minutes based on clinical content and patient response to the material.
- Treatment as Usual — OTHERParticipants will continue to engage in medical care as usual for 8 weeks.
- Telemedicine-based Cognitive Behavioral Therapy (TCBT) — OTHERParticipants assigned to TCBT will receive 8 sessions of cognitive behavioral therapy using telemedicine rather than face-to face office visits.
Study Details
Posttraumatic headache (PTH) is a common and highly disabling consequence of traumatic brain injury (TBI) in U.S. military service members and veterans. Cognitive Behavioral Therapy for PTH has been shown to significantly improve disability outcomes in veterans with persistent PTH when delivered in-person. Telemedicine platforms can dramatically increase access to evidence-based care. However, whether CBT for PTH retains its effectiveness when delivered through a telemedicine platform has yet to be established. The purpose of this 3-arm randomized clinical trial is to compare Clinic-based Cognitive-Behavioral Therapy (CCBT) to Telemedicine-based Cognitive Behavioral Therapy (TCBT) and to treatment as usual (TAU) in 525 service members and veterans with chronic posttraumatic headaches (PTH) at 4 VA medical centers\* and 3 military treatment facilities across the U.S. Participants will be assessed for headache-related disability, headache experience, and psychiatric comorbidities across multiple time points. \*VA Palo Alto Health Care System is temporarily randomizing into TAU and TCBT only.
Key Dates
- Start date
- Aug 24, 2023
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 525 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Clinic-based Cognitive Behavioral Therapy (CCBT)CCBT provides CBT for posttraumatic headache through 8 face-to-face, in-clinic sessions.
- Active Comparator: Telemedicine-based Cognitive Behavioral Therapy (TCBT)TCBT provides 8-sessions of CBT for posttraumatic headache using telemedicine technology rather than attending in-office sessions. Additionally, TCBT includes instructions for each session specific to the mechanics of a telehealth encounter (e.g., asking participant for name, location, and accessible phone number for location in case of technical failure or crisis). All TCBT participants must be enrolled at the MTF or VA from which they were recruited, and the treatment facility will be notified that they are receiving TCBT in case a crisis arises and needs to be managed by the site.
- Active Comparator: Treatment As UsualParticipants will continue to engage in clinical care as usual for 8 weeks. Research staff will call the TAU participants weekly to assess for adverse events. Research staff at each site will be trained on standardized assessment of usual care activities using forms adapted from our single-site trial.
Primary Outcome Measure
Change in Headache Impact Test (HIT-6) [ Time Frame: Baseline to 3-month follow-up ]
Central Contacts
- Nicole A Brackins, MS210-450-8076
- Fermin A Carrizales210-562-6724
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | Revati Mummaneni, MD (PRINCIPAL_INVESTIGATOR) |
| VA Palo Alto Health Care System | Palo Alto | California | 94304 | Molly Timmerman, DO (PRINCIPAL_INVESTIGATOR) |
| Tripler Army Medical Center (Desmond Doss Health Clinic, Schofield Barracks) | Honolulu | Hawaii | 96819 | Chad Grills, PhD (PRINCIPAL_INVESTIGATOR) |
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20889 | - |
| Minneapolis VA Health Care System | Minneapolis | Minnesota | 55417 | Rebecca Vogsland, DPT (PRINCIPAL_INVESTIGATOR) |
| Carl R. Darnall Army Medical Center (Fort Cavazos) | Killeen | Texas | 76544 | Scot Engel, PsyD (PRINCIPAL_INVESTIGATOR) |
| Brooke Army Medical Center | San Antonio | Texas | 78234 | Alexis Nelson, MD (PRINCIPAL_INVESTIGATOR) |
| South Texas Veterans Health Care System | San Antonio | Texas | 78229 | Ashley Lujan, DO (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
Related Studies
- Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBIPHASE2 · Recruiting · Henry M. Jackson Foundation for the Advancement of Military Medicine · Fort Bragg, North Carolina
- Ketamine, SGB and Combination Treatment for TBI-associated Headache or PTSDPHASE2 · Recruiting · Northwestern University · Chicago, Illinois